| # | Drug | Count |
|---|---|---|
| 0 | GABAPENTIN | 26 |
| 1 | BUPROPION HYDROCHLORIDE | 19 |
| 2 | PREDNISONE | 18 |
| 3 | PREGABALIN | 17 |
| 4 | ADALIMUMAB | 16 |
| 5 | ROSUVASTATIN | 16 |
| 6 | CYCLOSPORINE | 15 |
| 7 | FUROSEMIDE | 15 |
| 8 | METHOTREXATE SODIUM | 15 |
| 9 | ATORVASTATIN CALCIUM | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CASTOR OIL | 2 | 0.0104 |
| 1 | SODIUM NITROPRUSSIDE | 3 | 0.0078 |
| 2 | NATALIZUMAB-SZTN | 1 | 0.0042 |
| 3 | HYDRALAZINE HYDROCHLORIDE AND ISOSORBIDE DINITRATE | 1 | 0.0023 |
| 4 | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | 2 | 0.0018 |
| 5 | HYDROCORTISONE VALERATE | 1 | 0.0016 |
| 6 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | 2 | 0.0015 |
| 7 | FAMOTITINE | 4 | 0.0014 |
| 8 | OXYBUTYNIN CHLORIDE | 11 | 0.0012 |
| 9 | DICHLORPHENAMIDE | 2 | 0.0012 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Plasma Volume Expander [EPC] | 2 | 0.0006 |
| 1 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 2 | 0.0006 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 3 | PCSK9 Inhibitor [EPC] | 12 | 0.0005 |
| 4 | Ergot Derivative [EPC] | 2 | 0.0004 |
| 5 | Human Immunoglobulin G [EPC] | 8 | 0.0004 |
| 6 | beta3-Adrenergic Agonist [EPC] | 11 | 0.0002 |
| 7 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 8 | Potassium-sparing Diuretic [EPC] | 3 | 0.0002 |
| 9 | Chloride Channel Activator [EPC] | 2 | 0.0002 |